Hospital Pharmacy - April 2018 - 115

115

Krasniak et al
Table 1. Survey of Residency Programs: Institution and
Residency Program Characteristics.
Institution bed number

N (%)

200-299
300-449
450-599
600-799
800-999
≥1000

3 (6.8)
3 (6.8)
8 (18.2)
12 (27.2)
10 (22.7)
8 (18.2)

Years residency program accredited by ASHP

N (%)

≤1 year
1-5 years
6-10 years
11-15 years
≥15 years

1 (2.3)
2 (4.5)
2 (4.5)
8 (18.2)
31 (70.5)

Note. ASHP = American Society of Health-System Pharmacists.

Table 2. Survey of Pharmacy Residency Programs: Residency
Program Learning Experiences.
Required learning experiences
>75%

50-75%

** Internal medicine/ **
adult medicine
**
** Administration
** Orientation
**
** Critical Care

Research
Ambulatory
care
Pharmacy
operations

<50%
**
**
**
**
**
**
**
**
**
**
**
**

Drug information
Pediatrics
Infectious disease
Medication safety
Cardiology
Emergency medicine
Anticoagulation
Family medicine
Oncology
Informatics
Transplant
HIV/AIDS

Elective learning experiences
>75%
** Oncology
** Emergency
medicine

50-75%
** Infectious
disease
** Cardiology
** Transplant
** Critical care
** Ambulatory
care

<50%
**
**
**
**
**
**
**
**
**
**
**
**
**
**
**
**

Pediatrics
Pharmacy informatics
Psychiatry
Anticoagulation
HIV/AIDS
Drug information
Endocrinology/
diabetes
Women's health
Internal medicine
Geriatrics
Medication safety
Research
Family medicine
Administration
Pharmacy operations
Other

we did not find a change in the percentage of time residents
spent on either of these areas over the 5-year survey period (P =
.858, P = .699), respectively. While there has been some increase
in staffing requirements over the 5-year survey period, from a
median of 14% to a median of 15% of time, this finding was not
statistically significant (P = .086). Percent of time residents
spent on research experiences over the 5-year survey period
remains the same at a median of 10% of time (P = .34).
Resident career path choices did change significantly over
the 5-year survey period. Our results demonstrated an increase
from a median of 50% to a median of 70% of residents pursuing PGY-2 or fellowship training after completing PGY-1
pharmacy residency (P = .026, Figure 3). The survey showed
a decrease in pharmacy residents that accepted a hospitalbased clinical/staff position in the year directly after PGY-1
residency training, from a median of 50% to a median of 30%
(P = .014, Figure 4). Fewer than 5% of residents were found
to go directly into academia or ambulatory care practice sites
immediately following PGY-1 residency training, and this did
not change over the 5-year survey period.
Of the residency programs that responded to the survey,
54% require either PGY-1 pharmacy residency training or 3
years of hospital work experience as a minimum qualification for a hospital staff pharmacist position. Of those institutions, 29% require PGY-1 pharmacy residency training and
25% require either PGY-1 pharmacy residency or at least 3
years of hospital work experience. The survey showed that
32% of institutions did not require any hospital or residency
experience as a minimum qualification for a hospital staff
pharmacist position. The remaining 14% of institutions
replied "none of the above" or "other," which some responders specified that qualification requirements were "PharmD
with residency preferred," "depends on the position," or "6
months of hospital experience."

Discussion
As pharmacy practice at academic medical centers continues
to evolve, we sought to understand how PGY-1 pharmacy
residency programs might also be adjusting. Although our
survey results reveal some significant changes in specific
areas, consistent large-scale changes are not evident over the
5-year historical period. While significant changes have been
occurring within individual programs, many of these changes
did not transcend across programs.
The most common change to program design was an increase
in the amount of teaching experiences provided to PGY-1 residents. This was the only program design change that was found
to be significant. We found a near doubling of these types of
learning experiences occurring over the 5 year survey period.
This could likely be due to a number of factors. First, the updated
ASHP Competency Area, Goals, and Objectives document was
approved in 2014 which incorporated new goals and objectives
for teaching, education, and dissemination of knowledge for
PGY-1 pharmacy residency programs.7 The timing of this



Table of Contents for the Digital Edition of Hospital Pharmacy - April 2018

Ed Board
TOC
HPX
Why Is Burnout a Taboo?
Stability of 2 mg/mL Adenosine Solution in Polyvinyl Chloride and Polyolefin Infusion Bags
Glecaprevir/Pibrentasvir
New Medications in the Treatement of Acute Decompensated Heart Failure
The Prescription Drug User Fee Act: Cause for Concern?
ISMP Medication Error Report Analysis
ISMP Adverse Drug Reactions
Development and Implementation of a Combined Master of Science and PGY1/PGY2 Health-System Pharmacy Administration Residency Program at a Large Community Teaching Hospital
Breadth of Statistical Training Among Pharmacy Residency Programs Across the United States
Antihypertensive Prescription Pattern and Compliance to JNC 7 and JNC 8 at Tertiary Care Government Hospital, Hyderabad, India: A Cross-sectional Retrospective Study
Changes in Pharmacy Residency Training Design Between 2012 and 2017: A Perspective of Academic Medical Centers
Incidence of Hypoglycemia in Burn Patients: A Focus for Process Improvement
Physical Compatibility of Micafungin With Sodium Bicarbonate Hydration Fluids Commonly Used With High-Dose Methotrexate Chemotherapy
Hospital Pharmacy - April 2018 - Cover1
Hospital Pharmacy - April 2018 - Cover2
Hospital Pharmacy - April 2018 - Ed Board
Hospital Pharmacy - April 2018 - TOC
Hospital Pharmacy - April 2018 - HPX
Hospital Pharmacy - April 2018 - Why Is Burnout a Taboo?
Hospital Pharmacy - April 2018 - Stability of 2 mg/mL Adenosine Solution in Polyvinyl Chloride and Polyolefin Infusion Bags
Hospital Pharmacy - April 2018 - 74
Hospital Pharmacy - April 2018 - Glecaprevir/Pibrentasvir
Hospital Pharmacy - April 2018 - 76
Hospital Pharmacy - April 2018 - 77
Hospital Pharmacy - April 2018 - 78
Hospital Pharmacy - April 2018 - 79
Hospital Pharmacy - April 2018 - 80
Hospital Pharmacy - April 2018 - 81
Hospital Pharmacy - April 2018 - 82
Hospital Pharmacy - April 2018 - 83
Hospital Pharmacy - April 2018 - 84
Hospital Pharmacy - April 2018 - New Medications in the Treatement of Acute Decompensated Heart Failure
Hospital Pharmacy - April 2018 - 86
Hospital Pharmacy - April 2018 - 87
Hospital Pharmacy - April 2018 - The Prescription Drug User Fee Act: Cause for Concern?
Hospital Pharmacy - April 2018 - 89
Hospital Pharmacy - April 2018 - ISMP Medication Error Report Analysis
Hospital Pharmacy - April 2018 - 91
Hospital Pharmacy - April 2018 - 92
Hospital Pharmacy - April 2018 - ISMP Adverse Drug Reactions
Hospital Pharmacy - April 2018 - 94
Hospital Pharmacy - April 2018 - 95
Hospital Pharmacy - April 2018 - Development and Implementation of a Combined Master of Science and PGY1/PGY2 Health-System Pharmacy Administration Residency Program at a Large Community Teaching Hospital
Hospital Pharmacy - April 2018 - 97
Hospital Pharmacy - April 2018 - 98
Hospital Pharmacy - April 2018 - 99
Hospital Pharmacy - April 2018 - 100
Hospital Pharmacy - April 2018 - Breadth of Statistical Training Among Pharmacy Residency Programs Across the United States
Hospital Pharmacy - April 2018 - 102
Hospital Pharmacy - April 2018 - 103
Hospital Pharmacy - April 2018 - 104
Hospital Pharmacy - April 2018 - 105
Hospital Pharmacy - April 2018 - 106
Hospital Pharmacy - April 2018 - Antihypertensive Prescription Pattern and Compliance to JNC 7 and JNC 8 at Tertiary Care Government Hospital, Hyderabad, India: A Cross-sectional Retrospective Study
Hospital Pharmacy - April 2018 - 108
Hospital Pharmacy - April 2018 - 109
Hospital Pharmacy - April 2018 - 110
Hospital Pharmacy - April 2018 - 111
Hospital Pharmacy - April 2018 - 112
Hospital Pharmacy - April 2018 - Changes in Pharmacy Residency Training Design Between 2012 and 2017: A Perspective of Academic Medical Centers
Hospital Pharmacy - April 2018 - 114
Hospital Pharmacy - April 2018 - 115
Hospital Pharmacy - April 2018 - 116
Hospital Pharmacy - April 2018 - 117
Hospital Pharmacy - April 2018 - 118
Hospital Pharmacy - April 2018 - 119
Hospital Pharmacy - April 2018 - 120
Hospital Pharmacy - April 2018 - Incidence of Hypoglycemia in Burn Patients: A Focus for Process Improvement
Hospital Pharmacy - April 2018 - 122
Hospital Pharmacy - April 2018 - 123
Hospital Pharmacy - April 2018 - 124
Hospital Pharmacy - April 2018 - Physical Compatibility of Micafungin With Sodium Bicarbonate Hydration Fluids Commonly Used With High-Dose Methotrexate Chemotherapy
Hospital Pharmacy - April 2018 - 126
Hospital Pharmacy - April 2018 - 127
Hospital Pharmacy - April 2018 - 128
Hospital Pharmacy - April 2018 - Cover3
Hospital Pharmacy - April 2018 - Cover4
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2020
https://www.nxtbook.com/nxtbooks/sage/psychologicalscience_demo
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2020
https://www.nxtbook.com/nxtbooks/sage/fai_202009
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_august2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
https://www.nxtbook.com/nxtbooks/sage/fai_201909
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
https://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
https://www.nxtbook.com/nxtbooks/sage/tec_20180810
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
https://www.nxtbook.com/nxtbooks/sage/fai_201807
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
https://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
https://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
https://www.nxtbook.com/nxtbooks/sage/fai_201706
https://www.nxtbook.com/nxtbooks/sage/fai_201607
https://www.nxtbookmedia.com